Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Metabolic Changes in Chronic Hepatitis C Patients who Carry IFNL4-ΔG and Achieve Sustained Virologic Response with Direct-Acting Antiviral Therapy.

Emmanuel B, El-Kamary SS, Magder LS, Stafford KA, Charurat ME, Chairez C, McLaughlin M, Hadigan C, Prokunina-Olsson L, O'Brien TR, Masur H, Kottilil S.

J Infect Dis. 2019 Aug 26. pii: jiz435. doi: 10.1093/infdis/jiz435. [Epub ahead of print]

PMID:
31504644
2.

Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC.

Antiviral Res. 2019 Jul;167:45-67. doi: 10.1016/j.antiviral.2019.04.006. Epub 2019 Apr 8. Review.

PMID:
30974127
3.

Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients.

Emmanuel B, El-Kamary SS, Magder LS, Stafford KA, Charurat ME, Poonia B, Chairez C, McLaughlin M, Hadigan C, Masur H, Kottilil S.

Hepatol Int. 2019 May;13(3):270-276. doi: 10.1007/s12072-019-09941-8. Epub 2019 Mar 5.

PMID:
30835046
4.

Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Umlauf A, Franklin D, Ghate M, Abimiku A, Charurat M, Letendre S, Ellis RJ, Mehendale S, Blattner WA, Royal W 3rd, Marcotte TD, Heaton RK, Grant I, McCutchan JA.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):e30-e35. doi: 10.1097/QAI.0000000000001906.

PMID:
30422905
5.

Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa.

Aliyu G, El-Kamary SS, Abimiku A, Blattner W, Charurat M.

PLoS One. 2018 Sep 7;13(9):e0191387. doi: 10.1371/journal.pone.0191387. eCollection 2018.

6.

Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Ndembi N, Aliyu A, Dakum P, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

J Neurovirol. 2018 Dec;24(6):712-719. doi: 10.1007/s13365-018-0667-8. Epub 2018 Aug 30.

7.

Reply to Walker et al.

El-Kamary SS, Hashem M, Jhaveri R, El-Ghazaly H.

Clin Infect Dis. 2018 Aug 31;67(6):984. doi: 10.1093/cid/ciy240. No abstract available.

PMID:
29617734
8.

Risk-Based Hepatitis C Screening in Pregnancy Is Less Reliable Than Universal Screening: A Retrospective Chart Review.

Boudova S, Mark K, El-Kamary SS.

Open Forum Infect Dis. 2018 Feb 17;5(3):ofy043. doi: 10.1093/ofid/ofy043. eCollection 2018 Mar.

9.

Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.

Jumare J, Ndembi N, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Dakum P, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

Clin Infect Dis. 2018 Apr 17;66(9):1448-1453. doi: 10.1093/cid/cix1019.

10.

In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.

Shin SH, Thomas S, Raney SG, Ghosh P, Hammell DC, El-Kamary SS, Chen WH, Billington MM, Hassan HE, Stinchcomb AL.

J Control Release. 2018 Jan 28;270:76-88. doi: 10.1016/j.jconrel.2017.11.034. Epub 2017 Nov 22.

PMID:
29175139
11.

Immunologic response to antiretroviral therapy by age among treatment-naive patients in Sub-Saharan Africa.

Stafford KA, Magder LS, Hungerford LL, Guralnik JM, El-Kamary SS, Baumgarten M, Redfield RR.

AIDS. 2018 Jan 2;32(1):25-34. doi: 10.1097/QAD.0000000000001663.

PMID:
29028658
12.

Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.

Hashem M, Jhaveri R, Saleh DA, Sharaf SA, El-Mougy F, Abdelsalam L, Shardell MD, El-Ghazaly H, El-Kamary SS.

Clin Infect Dis. 2017 Sep 15;65(6):999-1005. doi: 10.1093/cid/cix445.

13.

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB; DMID 08-0006 Tularemia Vaccine Study Group.

Vaccine. 2017 Aug 24;35(36):4730-4737. doi: 10.1016/j.vaccine.2017.07.024. Epub 2017 Jul 24.

14.

Perinatal HIV Infection and Exposure and Their Association With Dental Caries in Nigerian Children.

Coker M, El-Kamary SS, Enwonwu C, Blattner W, Langenberg P, Mongodin E, Akhigbe P, Obuekwe O, Omoigberale A, Charurat M.

Pediatr Infect Dis J. 2018 Jan;37(1):59-65. doi: 10.1097/INF.0000000000001702.

15.

Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.

Jumare J, Sunshine S, Ahmed H, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Umlauf A, Cherner M, Abimiku A, Charurat M, Li JZ, Blattner WA, Royal W 3rd.

J Neurovirol. 2017 Jun;23(3):474-482. doi: 10.1007/s13365-017-0520-5. Epub 2017 Feb 27.

16.

Racial disparity in all-cause mortality among hepatitis C virus-infected individuals in a general US population, NHANES III.

Emmanuel B, Shardell MD, Tracy L, Kottilil S, El-Kamary SS.

J Viral Hepat. 2017 May;24(5):380-388. doi: 10.1111/jvh.12656. Epub 2016 Dec 1.

17.

Assessing the Awareness of Egyptian Medical Students about Responsible Conduct of Research and Research Ethics: Impact of an Educational Campaign.

El-Shinawi M, Mohamed KO, Fouad YA, Fahmy YM, Asar HA, Khalil MG, Anestidou L, El-Kamary SS, Mohamed MM.

Account Res. 2016;23(4):199-218. doi: 10.1080/08989621.2015.1127762.

PMID:
26647065
18.

Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors.

Jhaveri R, Hashem M, El-Kamary SS, Saleh DA, Sharaf SA, El-Mougy F, Abdelsalam L, Ehab M, El-Ghazaly H.

Open Forum Infect Dis. 2015 Jun 26;2(2):ofv089. doi: 10.1093/ofid/ofv089. eCollection 2015 Apr.

19.

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.

Frey SE, Wald A, Edupuganti S, Jackson LA, Stapleton JT, El Sahly H, El-Kamary SS, Edwards K, Keyserling H, Winokur P, Keitel W, Hill H, Goll JB, Anderson EL, Graham IL, Johnston C, Mulligan M, Rouphael N, Atmar R, Patel S, Chen W, Kotloff K, Creech CB, Chaplin P, Belshe RB.

Vaccine. 2015 Sep 22;33(39):5225-34. doi: 10.1016/j.vaccine.2015.06.075. Epub 2015 Jul 2.

PMID:
26143613
20.

Investigating the informed consent process, therapeutic misconception and motivations of Egyptian research participants: a qualitative pilot study.

Mansour H, Zaki N, Abdelhai R, Sabry N, Silverman H, El-Kamary SS.

East Mediterr Health J. 2015 May 19;21(3):155-63.

21.

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

Winokur PL, Patel SM, Brady R, Chen WH, El-Kamary SS, Edwards K, Creech CB, Frey S, Keitel WA, Belshe R, Walter E, Bellamy A, Hill H.

J Infect Dis. 2015 Aug 15;212(4):525-30. doi: 10.1093/infdis/jiv087. Epub 2015 Feb 23.

22.

Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt.

El-Kamary SS, Hashem M, Saleh DA, Ehab M, Sharaf SA, El-Mougy F, Abdelsalam L, Jhaveri R, Aboulnasr A, El-Ghazaly H.

J Infect. 2015 May;70(5):512-9. doi: 10.1016/j.jinf.2015.01.009. Epub 2015 Jan 23.

PMID:
25623176
23.

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Hungerford L, Obasanya J, Blattner W.

BMC Infect Dis. 2014 Dec 13;14:675. doi: 10.1186/s12879-014-0675-0.

24.

From intense rejection to advocacy: how Muslim clerics were engaged in a polio eradication initiative in Northern Nigeria.

Nasir SG, Aliyu G, Ya'u I, Gadanya M, Mohammad M, Zubair M, El-Kamary SS.

PLoS Med. 2014 Aug 5;11(8):e1001687. doi: 10.1371/journal.pmed.1001687. eCollection 2014 Aug.

25.

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

Reddy SK, Reilly C, Zhan M, Mindikoglu AL, Jiang Y, Lane BF, Alexander HR, Culpepper WJ, El-Kamary SS.

Med Oncol. 2014 Jun;31(6):971. doi: 10.1007/s12032-014-0971-y. Epub 2014 May 6.

26.

Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.

Reddy SK, Zhan M, Alexander HR, El-Kamary SS.

World J Gastroenterol. 2013 Dec 7;19(45):8301-11. doi: 10.3748/wjg.v19.i45.8301.

27.

Predictors of early treatment discontinuation in a cohort of patients treated with boceprevir-based therapy for hepatitis C infection.

Majid A, McAninch J, Morgan DJ, El Kamary SS, Zhan M, Kapelusznik L, Talwani R.

J Viral Hepat. 2014 Aug;21(8):585-9. doi: 10.1111/jvh.12201. Epub 2013 Nov 13.

PMID:
24224781
28.

Inaccurate weight perception is associated with extreme weight-management practices in U.S. high school students.

Ibrahim C, El-Kamary SS, Bailey J, St George DM.

J Pediatr Gastroenterol Nutr. 2014 Mar;58(3):368-75. doi: 10.1097/MPG.0000000000000231.

29.

Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.

El-Kamary SS, Cohen MB, Bourgeois AL, Van De Verg L, Bauers N, Reymann M, Pasetti MF, Chen WH.

Clin Vaccine Immunol. 2013 Nov;20(11):1764-70. doi: 10.1128/CVI.00464-13. Epub 2013 Sep 18. Erratum in: Clin Vaccine Immunol. 2014 Apr;21(4):602.

30.

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Ezati N, Mosunmola I, Hungerford L, Brown C, Tracy KJ, Obasanya J, Blattner W.

Tuberc Res Treat. 2013;2013:650561. doi: 10.1155/2013/650561. Epub 2013 Jul 16.

31.

Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W.

PLoS One. 2013 May 9;8(5):e63170. doi: 10.1371/journal.pone.0063170. Print 2013.

32.

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.

Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB Jr, Hay CM, Newman FK, Hill HR, Zhang Y, Chaplin P, Tary-Lehmann M, Belshe RB.

Vaccine. 2013 Jun 24;31(29):3025-33. doi: 10.1016/j.vaccine.2013.04.050. Epub 2013 May 9.

33.

Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4.

Shaker O, Bassiony H, El Raziky M, El-Kamary SS, Esmat G, El-Ghor AM, Mohamed MM.

Mediators Inflamm. 2013;2013:392746. doi: 10.1155/2013/392746. Epub 2013 Mar 14.

34.

Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.

El-Kamary SS, Mohamed MM, El-Raziky M, Shardell MD, Shaker OG, ElAkel WA, Esmat G.

Liver Int. 2013 Aug;33(7):982-90. doi: 10.1111/liv.12139. Epub 2013 Mar 20.

35.

Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection.

Abdelwahab SF, Hashem M, Galal I, Sobhy M, Abdel-Ghaffar TS, Galal G, Mikhail N, El-Kamary SS, Waked I, Strickland GT.

J Clin Virol. 2013 May;57(1):24-8. doi: 10.1016/j.jcv.2013.01.005. Epub 2013 Jan 29.

PMID:
23375237
36.

Breaking community barriers to polio vaccination in Northern Nigeria: the impact of a grass roots mobilization campaign (Majigi).

Nasiru SG, Aliyu GG, Gasasira A, Aliyu MH, Zubair M, Mandawari SU, Waziri H, Nasidi A, El-Kamary SS.

Pathog Glob Health. 2012 Jul;106(3):166-71. doi: 10.1179/2047773212Y.0000000018.

37.

Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt.

Shata MT, Daef EA, Zaki ME, Abdelwahab SF, Marzuuk NM, Sobhy M, Rafaat M, Abdelbaki L, Nafeh MA, Hashem M, El-Kamary SS, Shardell MD, Mikhail NN, Strickland GT, Sherman KE.

Trans R Soc Trop Med Hyg. 2012 Oct;106(10):613-8. doi: 10.1016/j.trstmh.2012.07.004. Epub 2012 Aug 28.

PMID:
22938992
38.

Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus.

El-Kamary SS, Hashem M, Saleh DA, Abdelwahab SF, Sobhy M, Shebl FM, Shardell MD, Strickland GT, Shata MT.

J Pediatr. 2013 Jan;162(1):148-54. doi: 10.1016/j.jpeds.2012.06.057. Epub 2012 Aug 9.

39.

Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.

Ramirez K, Wahid R, Richardson C, Bargatze RF, El-Kamary SS, Sztein MB, Pasetti MF.

Clin Immunol. 2012 Aug;144(2):98-108. doi: 10.1016/j.clim.2012.05.006. Epub 2012 May 24.

PMID:
22710446
40.

Estimating incidence rates with misclassified disease status: a likelihood-based approach, with application to hepatitis C virus.

Shebl FM, El-Kamary SS, Shardell M, Langenberg P, Dorgham LS, Maguire JH, Magder LS.

Int J Infect Dis. 2012 Jul;16(7):e527-31. doi: 10.1016/j.ijid.2012.02.017. Epub 2012 Apr 28.

41.

Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Abdelwahab SF, Zakaria Z, Sobhy M, Rewisha E, Mahmoud MA, Amer MA, Del Sorbo M, Capone S, Nicosia A, Folgori A, Hashem M, El-Kamary SS.

Clin Vaccine Immunol. 2012 May;19(5):780-6. doi: 10.1128/CVI.00050-12. Epub 2012 Mar 21.

42.

Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre.

Abdelwahab S, Rewisha E, Hashem M, Sobhy M, Galal I, Allam WR, Mikhail N, Galal G, El-Tabbakh M, El-Kamary SS, Waked I, Strickland GT.

Trans R Soc Trop Med Hyg. 2012 Feb;106(2):98-103. doi: 10.1016/j.trstmh.2011.10.003. Epub 2011 Dec 22.

PMID:
22197011
43.

Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children.

Esmat G, Hashem M, El-Raziky M, El-Akel W, El-Naghy S, El-Koofy N, El-Sayed R, Ahmed R, Atta-Allah M, Hamid MA, El-Kamary SS, El-Karaksy H.

Liver Int. 2012 Mar;32(3):449-56. doi: 10.1111/j.1478-3231.2011.02643.x. Epub 2011 Sep 15.

44.

Vaccines for enteric infections.

Chen WH, El-Kamary SS.

Curr Opin Gastroenterol. 2012 Jan;28(1):18-23. doi: 10.1097/MOG.0b013e32834cf36a. Review.

PMID:
22080824
45.

Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.

El-Kamary SS, Billington M, Deitz S, Colby E, Rhinehart H, Wu Y, Blackwelder W, Edelman R, Lee A, King A.

Mol Ther. 2012 Jan;20(1):214-20. doi: 10.1038/mt.2011.235. Epub 2011 Nov 8.

46.

All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.

El-Kamary SS, Jhaveri R, Shardell MD.

Clin Infect Dis. 2011 Jul 15;53(2):150-7. doi: 10.1093/cid/cir306. Epub 2011 Jun 10.

47.

Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey.

Shardell MD, Alley DE, Hicks GE, El-Kamary SS, Miller RR, Semba RD, Ferrucci L.

Nutr Res. 2011 Mar;31(3):178-89. doi: 10.1016/j.nutres.2011.03.003.

48.

Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment?

Arshad M, El-Kamary SS, Jhaveri R.

J Viral Hepat. 2011 Apr;18(4):229-36. doi: 10.1111/j.1365-2893.2010.01413.x. Epub 2011 Jan 7. Review.

PMID:
21392169
49.

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Hashem M, El-Karaksy H, Shata MT, Sobhy M, Helmy H, El-Naghi S, Galal G, Ali ZZ, Esmat G, Abdelwahab SF, Strickland GT, El-Kamary SS.

J Infect Dis. 2011 Mar 15;203(6):854-61. doi: 10.1093/infdis/jiq123. Epub 2011 Jan 21.

50.

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.

El-Kamary SS, Pasetti MF, Mendelman PM, Frey SE, Bernstein DI, Treanor JJ, Ferreira J, Chen WH, Sublett R, Richardson C, Bargatze RF, Sztein MB, Tacket CO.

J Infect Dis. 2010 Dec 1;202(11):1649-58. doi: 10.1086/657087. Epub 2010 Oct 27. Erratum in: J Infect Dis. 2011 Apr 1;203(7):1036.

Supplemental Content

Loading ...
Support Center